Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
Study selection The criteria for including studies in this meta-analysis were as follows: (1) (i) randomized controlled trials (RCTs) comparing different AOMs with placebo, including glucagon-like peptide 1 receptor agonist (GLP-1 RA), dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 RAs, GLP-1 and glucagon receptor (GCGR) dual-agonist, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and bimagrumab
Shorter needles are much safer and are better tolerated and less painful
Life (2009)
Liu, Tianqi, et al
US$ 22.71
US$ 23.10
US$ 27.17
US$ 25.78
US$ 28.08
US$ 26.43
US$ 26.16
